NCT03135184View on ClinicalTrials.gov

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

NAUnknownINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

January 7, 2019

Study Completion Date

August 31, 2019

Conditions

Homozygous Familial HypercholesterolemiaHoFH

Interventions

DEVICE

HDL Therapeutics PDS-2 System

Delipidation of plasma HDL to reduce coronary atheroma

Trial Locations (1)

90048

Cedars-Sinai Medical Center (CSMC), Los Angeles

Sponsors

Lead Sponsor

HDL Therapeutics

All Listed Sponsors

collaborator

MedStar Heart and Vascular Institute

UNKNOWN

lead

HDL Therapeutics

INDUSTRY